This Results UK report co-authored with Results Canada, outlines the case for meeting the financial targets for TB research and development to ensure all people can benefit from scientific progress. Investing in TB research offers not only financial returns but also strengthens health systems, builds research capacity, improves health outcomes, and enhances global health security for all.
Mesothelioma is a rare type of lung cancer, typically caused by Asbestos inhalation and commonly...
The GIRFT Tuberculosis (TB) report is a comprehensive, data-driven national review of TB services...
In 2020 the COVID-19 pandemic hit the global population, causing lockdowns and economic...
This guideline covers diagnosing, assessing, and treating community-acquired and hospital-acquired...
COPD is the second most common cause for hospital admission and the third leading cause of death...